Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-1.9%
5Y CAGR+14.7%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-1.9%/yr
vs +69.5%/yr prior
5Y CAGR
+14.7%/yr
Recent deceleration
Acceleration
-71.4pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$116.71M-20.5%
2024$146.71M+10.9%
2023$132.28M+7.1%
2022$123.54M+8.6%
2021$113.73M+93.5%
2020$58.76M+109.1%
2019$28.11M+87.7%
2018$14.97M-